E-LIB Suche - Ergebnisse für: Atashrazm, Farzaneh

1

The polarity protein PARD3 and cancer:

Atashrazm, Farzaneh ; Ellis, Sarah
Oncogene. 40 (2021) 25 - p. 4245-4262 , 2021

Link: https://doi.org/10.1038/..

2

THE ROLE OF THE POLARITY PROTEIN PAR3 IN HAEMATOPOIESIS AND..:

Atashrazm, Farzaneh ; Dew, Alysha ; Jana, Metta..
Experimental Hematology. 76 (2019) - p. S56 , 2019

Link: https://doi.org/10.1016/..

3

Reduced glucocerebrosidase activity in monocytes from patie..:

Atashrazm, Farzaneh ; Hammond, Deborah ; Perera, Gayathri...
Scientific Reports. 8 (2018) 1 - p. , 2018

Link: https://doi.org/10.1038/..

4

LRRK2‐mediated Rab10 phosphorylation in immune cells from P..:

Atashrazm, Farzaneh ; Hammond, Deborah ; Perera, Gayathri...
Movement Disorders. 34 (2018) 3 - p. 406-415 , 2018

Link: https://doi.org/10.1002/..

5

Nigrostriatal pathology with reduced astrocytes in LRRK2 S9..:

Zhao, Ye ; Keshiya, Shikara ; Atashrazm, Farzaneh...
Neurobiology of Disease. 120 (2018) - p. 76-87 , 2018

Link: https://doi.org/10.1016/..

6

Fucoidan enhances the therapeutic potential of arsenic trio..:

Atashrazm, Farzaneh ; Lowenthal, Ray M. ; Dickinson, Joanne L...
Oncotarget. 7 (2016) 29 - p. 46028-46041 , 2016

Link: https://doi.org/10.18632..

7

LRRK2 inhibitors and their potential in the treatment of Pa..:

Atashrazm, Farzaneh ; Dzamko, Nicolas
Clinical Pharmacology: Advances and Applications. 8 (2016) - p. 177-189 , 2016

Link: https://doi.org/10.2147/..

8

Anti tumor activity of fucoidan in acute promyelocytic leuk..:

Atashrazm, Farzaneh ; Lowenthal, Ray M. ; Woods, Greg M...
Experimental Hematology. 43 (2015) 9 - p. S51 , 2015

Link: https://doi.org/10.1016/..

9

Fucoidan and Cancer: A Multifunctional Molecule withAnti-Tu..:

Atashrazm, Farzaneh ; Lowenthal, Ray ; Woods, Gregory..
Marine Drugs. 13 (2015) 4 - p. 2327-2346 , 2015

Link: https://doi.org/10.3390/..

10

Fucoidan Suppresses the Growth of Human Acute Promyelocytic..:

Atashrazm, Farzaneh ; Lowenthal, Ray M. ; Woods, Gregory M....
Journal of Cellular Physiology. 231 (2015) 3 - p. 688-697 , 2015

Link: https://doi.org/10.1002/..

11

Polymorphisms of the Methylene Tetrahydrofolate Reductase a..:

Atashrazm, Farzaneh ; Zaker, Farhad ; Aghaeipour, Mahnaz.
Laboratory Medicine. 42 (2011) 5 - p. 275-279 , 2011

Link: https://doi.org/10.1309/..

12

Frequency of CYP1A1*2C Polymorphism in Patients with Leukem..:

Razmkhah, Farnaz ; Pazhakh, Vahid ; Zaker, Farhad..
Laboratory Medicine. 42 (2011) 4 - p. 220-223 , 2011

Link: https://doi.org/10.1309/..

13

Methylenetetrahydrofolate Reductase Gene Polymorphisms and ..:

Vahid, Pazhakh ; Farnaz, Razmkhah ; Zaker, Farhad..
Laboratory Medicine. 41 (2010) 8 - p. 490-494 , 2010

Link: https://doi.org/10.1309/..

14

Reduced glucocerebrosidase activity in monocytes from patie..:

Atashrazm, Farzaneh ; Hammond, Deborah ; Perera, Gayathri...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193988/. , 2018

Link: http://www.ncbi.nlm.nih...

15

Nigrostriatal pathology with reduced astrocytes in LRRK2 S9..:

Zhao, Ye ; Keshiya, Shikara ; Atashrazm, Farzaneh...
Zhao , Y , Keshiya , S , Atashrazm , F , Gao , J , Ittner , L M , Alessi , D R , Halliday , G M , Fu , Y & Dzamko , N 2018 , ' Nigrostriatal pathology with reduced astrocytes in LRRK2 S910/S935 phosphorylation deficient knockin mice ' , Neurobiology of Disease , vol. 120 , pp. 76-87 . https://doi.org/10.1016/j.nbd.2018.09.003. , 2018

Link: https://researchers.mq.e..